Advocacy and Thought Leadership

The George Institute is focused on effective advocacy and thought leadership to improve health, aligned to our research goals.

We are engaging with key stakeholders, sharing insights and fostering discussions to stimulate debate, guide critical health policy decisions and facilitate evidence-based change.

By working with some of the world’s leading health voices we are amplifying our work in non-communicable diseases (NCDs) and injury and improving systems for prevention and treatment.

Our activities

A unique virtual collaboration has published a supplement in Latin America’s leading medical journal, exploring solutions to the common challenge of noncommunicable diseases and injury across Latin…
June 2022 -
News
‘I can relate to my study participants because I share the same traditions and customs that influence their health’ Priya is a Research Assistant at The George Institute who’s passionate about…
June 2022 -
Profile story
The George Institute for Global Health invites you to a #GeorgeTalks event on "A broad perspective of Mental Health” on Tuesday 28 June 2022 from 12:30pm to 1:30pm AEST. Join us as we seek to discuss…
June 2022 -
Event
A lot of progress has been made in Africa towards reducing deaths from communicable diseases, and there are opportunities to do the same for non-communicable diseases. Staff and students at The…
June 2022 -
Profile story
The second webinar of our 'Tea with Africa' series focuses on 'Clinical Trials – Are Global trials truly Global? How can LMICs play a more central role?'. The series is part of our Africa Partnership…
May 2022 -
Video
To mark International Clinical Trials Day, we asked Laurent Billot, Director of Biostatistics and Data Science at The George Institute for Global Health, and internationally recognised clinical…
May 2022 -
News
The George Institute for Global Health invites you to mark International Women’s Day on Wednesday 9 March 2022 from 1pm to 2pm (AEDT). Join us online for a panel discussion with notable experts…
February 2022 -
Event
Strong evidence exists to demonstrate the benefit of SGLT2 inhibitor use for indications beyond diabetes management, including kidney disease and heart failure, however the uptake to use SGLT2…
February 2022 -
Event
The George Institute for Global Health welcomes the appointment of new Board member, Timothy Longstaff. An accomplished senior executive and emerging non-executive director, Tim has led some of the…
January 2022 -
News
Please tell us a bit about yourself – where did you grow up? I grew up in Chimbote, an industrial city in the north of Peru. At age 15, I moved to Lima to pursue university studies. My mom was a high…
December 2021 -
Profile story